Birger Brodin Larsen
Professor
CNS Drug Delivery and Barrier Modelling
Universitetsparken 2
2100 København Ø
- 2009
- Published
Characterisation of in-vitro blood-brain barrier models
Helms, H. C., Eriksson, A. H., Waagepetersen, Helle S. & Larsen, Birger Brodin, 2009.Research output: Contribution to conference › Poster › Research
- Published
Discovery of ligands for the human intestinal di-/tripeptide transporter (hPEPT1) using af QSAR-assisted virtual screening strategy
Larsen, S. B., Omkvist, D. H., Larsen, Birger Brodin, Nielsen, C. U., Steffansen, B., Olsen, L. & Jørgensen, Flemming Steen, 2009, In: ChemMedChem. 4, 9, p. 1439-1445Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Intestinal gaboxadol absorption via PAT1 (SLC36A1): modified absorption in vivo following co-administration of L-tryptophan
Larsen, M., Larsen, R., Jensen, K. G., Larsen, Birger Brodin & Nielsen, C. U., 2009, In: British Journal of Pharmacology. 157, p. 1380-1389Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Peptide transporters in drug delivery; The human peptide transporter 1 (hPEPT1) translocates differently charged peptides in an electrogenic manner, indicating a varying proton coupling ration
Omkvist, D. H., Nielsen, C. U., Steffansen, B. & Larsen, Birger Brodin, May 2009. 1 p.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
- Published
In vitro blood-brain barrier models
Helms, H. C. C., Eriksson, A. H., Nielsen, C. U., Waagepetersen, Helle S. & Larsen, Birger Brodin, 18 Jul 2009.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
- Published
Transport of Gaboxadol via hPAT1 and rOAT1 in the absence and presence of 5-HTP
Broberg, M. L., Holm, R., Larsen, Birger Brodin, Jensen, K. G. & Nielsen, C. U., 29 Jul 2009. 1 p.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
- Published
Characterization of in-vitro blood-brain barrier models
Helms, H. C. C., Eriksson, A. H., Nielsen, C. U., Waagepetersen, Helle S. & Larsen, Birger Brodin, Aug 2009.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
- Published
Characterization of in vitro blood-brain barrier models
Helms, H. C. C., Eriksson, A. H., Nielsen, C. U., Waagepetersen, Helle S., Walls, Anne Byriel & Larsen, Birger Brodin, 9 Aug 2009. 1 p.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
- 2010
- Published
5-Hydroxy-L-tryptohan alters gaboxadol pharmacokinetics in rats: involvement of PAT1 and rOat1 in gaboxadol absorption and elimination
Broberg, M. L., Holm, R., Jensen, K. G., Sveigaard, C., Larsen, Birger Brodin & Nielsen, C. U., 2010, In: European Journal of Pharmaceutical Sciences. 39, 1-3, p. 68-75Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1)
Omkvist, D. H., Larsen, S. B., Nielsen, C. U., Steffansen, B., Olsen, L., Jørgensen, Flemming Steen & Larsen, Birger Brodin, 2010, In: The AAPS Journal. 12, 3, p. 385-396Research output: Contribution to journal › Journal article › Research › peer-review
ID: 1299175
Most downloads
-
1535
downloads
Design of prodrugs targeting the intestinal di/tri‐peptide transporter hPEPT1 (SLC15A1
Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
Published -
246
downloads
A bovine in vitro blood-brain barrier model under oxygenglucose deprivation (OGD) condition
Research output: Contribution to conference › Poster › Research
Published